期刊文献+

乳腺癌易感性及化疗敏感性与醌氧化还原酶1基因多态性的关系 被引量:2

Relationship between genetic polymorphisms of quinone oxidoreductase 1 and susceptibility and che- nosensitivity of breast cancer
原文传递
导出
摘要 目的探讨醌氧化还原酶1(NQ01)基因rsl800566多态性与乳腺癌易感性及化疗敏感性的关系。方法乳腺癌患者162名,健康对照者190例,乳腺癌患者分别接受多西紫杉醇+环磷酰胺(TC)方案和表阿霉素+5-氟尿嘧啶+环磷酰胺(FEC)方案化疗,采用TaqMan—MGB探针终点分型法检测NQ01rsl800566位点的多态性分布,并进行统计学分析。结果NQ01rsl800566位点C携带患者的危险度较对照组降低[P〈0.05,比值比(OR)=0.60,95%可信区间(CI)=0.37-0.97]。NQ01m1800566位点的rITr基因型是乳腺癌高危基因型(P〈0.05)。NQOlrsl800566位点C等位基因携带患者的化疗有效率为64.9%,显著高于TT基因型患者(P〈0.05)。TC方案化疗患者组中,NQOlrsl800566位点CT基因型患者的化疗有效率为71.0%,显著高于TT基因型(P〈0.05),但在FEC方案化疗组中差异无统计学意义(P〉0.05)。结论NQO!rsl800566的基因多态性可能与乳腺癌的发生发展有一定的关系。 Objective To expolre the relationshio between genetic polymorphisms of quinone oxidoreductase 1 (NQO1) and susceptibility and chenosensitivity of breast cancer.Methods Totally 162 breast cancer patients and 190 non-cancer female controls were selected.The breast cancer patients were treated with TC and FEC chemotherapy.The genotypes were detected by using TaqMan-MGB probe-based real time quantitive polymerase chain reaction technology method.Results The risk of breast cancer was decreased in NQO1rs1800566 C genetic carrier [odds ratio (OR) =0.60,95% confidence interval (CI) =0.37-0.97],compared with the controls.NQO1rs1800566 TT was the high risk genotype.The RR of C genetic carrier in NQO1rs1800566 cases was64.9%,which was significantly higher than that of the TT genotype.Among the cased administrated with TC regimens,the RR of CT genotype in NQO1rs1800566 cases was 71.0%,which was singificantly higher than that of the TT genotype.Conclusion The results indicated that the polymorphisms in NQO1 genes,which might be associated with breast cancer risk of Chinese women.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第4期684-686,共3页 Chinese Journal of Experimental Surgery
基金 浙江省医药卫生科学研究基金资助项目(2009A201)
关键词 醌氧化还原酶1 基因多态性 乳腺癌 化疗 Quinone oxidoreductase 1 Single nueleotide polymorphism Breast carcinoma Chemotherapeutic effect
  • 相关文献

参考文献9

  • 1许洪升,杜卫东,孙中武,唐先发,汤华阳,郝加虎,张铮,张学军.P2X7基因C489T和NQ01基因C609T多态性与原发性帕金森病遗传易感性分析[J].中华实验外科杂志,2007,24(11):1310-1312. 被引量:2
  • 2Siegel D, Gustafson DL, Dehn DL, et al. NAD (P) H : quinone oxi- doreductase 1 :role as a superoxide scavenger. Mol Pharmacol, 2004, 65 : 1238-1247.
  • 3王辛,柳晓义,曹伟红,李福年.乳腺癌发病风险及侵袭特性与白细胞介素-8和CXCR2基因多态性的关系[J].中华实验外科杂志,2012,29(7):1379-1382. 被引量:4
  • 4Northwood EL, Elliott F, Forman D, et al. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk. Pharmacogenet Genomics,2010,20:315-326.
  • 5Hong CC ,Ambrosone CB, Ahn J, et al. Genetic variability in iron-re- lated oxidative stress pathways ( Nrf2, NQO1, NOS3, and HO-1 ), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev ,2007,16 : 1784-1794.
  • 6Fagerholm R, Hofstetter B, Tommiska J, et al. NAD (P) H : quinone ox- idoreductase 1 NQO1 * 2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat Genet,2008 ,40 :844-853.
  • 7唐金海,胡亦钦,秦建伟,陆建伟,高长明,吴建中,龚建平,许芝银.亚甲基四氢叶酸还原酶和胸苷酸合成酶基因多态与乳腺癌化疗敏感性关系的研究[J].中华肿瘤防治杂志,2008,15(1):39-43. 被引量:6
  • 8Ettinger DS. Amrubicin for the treatment of small cell lung cancer: does effectiveness cross the Pacific. J Thorac Onco1,2007,2 : 160-165.
  • 9Dong N, Yu J, Wang C, et al. Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetax- el plus capecitabine. J Cancer Res Clin 0ncol,2012,138:1197-1203.

二级参考文献9

  • 1陆建伟,高长明,吴建中,孙小峰,王丽,冯继锋.亚甲基四氢叶酸还原酶基因C677T多态性与胃癌患者对5-FU化疗敏感性的关系[J].癌症,2004,23(8):958-962. 被引量:20
  • 2杜卫东,吕永梅,汤华阳,黄叔仁,陈大本,何祥成,王永清,孙松,张学军,徐昌娟(校).Leber遗传性视神经病变线粒体DNA原发性突变位点的分析[J].疾病控制杂志,2006,10(6):574-579. 被引量:9
  • 3Araki S, Omori Y, Lyn D, et al. Interleukin-8 is a molecular determi- nant of androgen independence and progression in prostate cancer. Cancer Res ,2007,67:6854-6862.
  • 4Singh S, Varney M, Singh RK. Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis. Cancer Res ,2009,69:411-415.
  • 5Danahue TR, Hines OJ. CXCR2 and RET single nucleotide polymor- phisms in pancreatic cancer. World J Surg,2009,33:710-715.
  • 6Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymor- phism increases the risk of atrophic gastritis and gastric cancer in Ja- pan. Cancer Epidemiol Biomarke Prey,2005,14:2487-2493.
  • 7Wang N,Zhou R,Wang C,et al. - 251 T/A polymorphism of the in- terleukin-8 gene and cancer risk:a HuGE review and meta-analysis based on 42 case-control studies. Mol Biol Rep,2012,39:2831-2841.
  • 8Kamali-Salvestani E, Aliparasti MR, Atefi S. Association of interleu- kin-8 (IL-8 or CXCL8) -251T/A and CXCR2 + 1208C/T gene pol- ymorphisms with breast cancer. Neoplasma,2007 ,54 :484-489.
  • 9张辉,林颖,肖颖,王三明,刘祥厦,王深明.转染ERα基因对MDA-MB-231乳腺癌细胞白细胞介素-8表达的影响[J].中华实验外科杂志,2010(5):585-587. 被引量:4

共引文献9

同被引文献8

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部